Download full-text PDF

Source
http://dx.doi.org/10.1016/0002-9378(53)90067-2DOI Listing

Publication Analysis

Top Keywords

maternal afibrinogenemia
4
afibrinogenemia associated
4
associated long-standing
4
long-standing intrauterine
4
intrauterine fetal
4
fetal death
4
maternal
1
associated
1
long-standing
1
intrauterine
1

Similar Publications

Article Synopsis
  • * This study compares the bleeding profiles and quality of life (QOL) of women and girls with hemophilia to those with VWD and rare bleeding disorders, using the ISTH Bleeding Assessment Tool and the EuroQOL questionnaire.
  • * Initial findings showed that 80 participants were enrolled, with a median age of 35 for hemophilia carriers and 15.5 for those with diagnosed bleeding disorders, revealing a significant family history of bleeding disorders in both groups.
View Article and Find Full Text PDF
Article Synopsis
  • Pregnant women with fibrinogen levels below 2 g/L are at high risk for severe postpartum hemorrhage and related complications, yet the criteria for identifying those needing fibrinogen therapy are unclear.
  • A UK study identified 124 cases of low fibrinogen in pregnant women, mainly linked to postpartum hemorrhage from events like placental abruption or trauma, with a low incidence of inherited conditions.
  • The study found high maternal and perinatal mortality rates, including 27 stillbirths and two maternal deaths due to massive hemorrhage, indicating the seriousness of low fibrinogen levels in this population.*
View Article and Find Full Text PDF

Congenital fibrinogen disorders (CFDs) are a heterogeneous group of rare congenital quantitative and/or qualitative fibrinogen deficiencies. The spectrum of molecular anomalies is broad, leading to several subtypes of fibrinogen disorders (ie, afibrinogenemia, hypofibrinogenemia, dysfibrinogenemia, and hypodysfibrinogenemia). Pregnancy in women with CFDs is a high-risk clinical situation, with an increased tendency for miscarriages, bleeding, and thrombosis.

View Article and Find Full Text PDF

Placenta accreta spectrum conservative management and coagulopathy: case series and systematic review.

Ultrasound Obstet Gynecol

June 2024

Division of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Maryland School of Medicine, Baltimore, MD, USA.

Objective: Management of placenta accreta spectrum (PAS) with the placenta kept in situ aims to preserve fertility and minimize blood loss. However, this method is associated with a risk of coagulopathy and subsequent bleeding. The aim of this study was to evaluate the occurrence and pathophysiology of coagulopathy in cases of PAS managed conservatively.

View Article and Find Full Text PDF
Article Synopsis
  • - The study aimed to investigate congenital dysfibrinogenemia (CD) in a Chinese family by assessing coagulation deficits and genetic causes.
  • - Blood tests revealed reduced fibrinogen activity in the proband and her father, while other family members showed normal results; two genetic variants were found in the FGA and FGG genes, with one variant likely linked to the condition.
  • - The inheritance pattern of CD in this family was determined to be autosomal dominant, indicating that the newly identified variant in the FGG gene may play a significant role in the development of the disorder.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!